Previously, we have reported that the Secreted Ly6/uPAR related protein-1 (SLURP1) serves an important immunomodulatory function in the ocular surface. Here, we examine the involvement of SLURP1 in regulating corneal angiogenic privilege. Slurp1 expression detected by QPCR, immunoblots and immunofluorescent stain, was significantly decreased in mouse corneas subjected to alkali burn-induced corneal neovascularization (CNV). Addition of exogenous SLURP1 (6XHis-tagged, E. coli expressed and partially purified using Ni-ion columns) significantly suppressed the tumor necrosis factor-a (TNF-a)-stimulated human umbilical cord vascular endothelial cell (HUVEC) tube formation. SLURP1 suppressed the HUVEC tube length, tube area and number of branch points, without affecting their viability and/or proliferation. Exogenous SLURP1 in HUVEC also suppressed the TNF-a-induced (i) interleukin-8 (IL-8) and TNF-a production, (ii) adhesion to different components of the extracellular matrix, (iii) migration, and (iv) nuclear localization of NFkB. Together, these results demonstrate that SLURP1 suppresses HUVEC tube formation by blocking nuclear translocation of NFkB, and suggest a potential role for SLURP1 in promoting corneal angiogenic privilege.
Introduction
Corneal avascularity-a primary requirement for the cornea to remain transparent-is regulated by several distinct and redundant mechanisms that work in concert (Azar, 2006; Barabino et al., 2012; Bock et al., 2013; Clements and Dana, 2011) . Corneal angiogenic privilege depends on the counterbalance between pro-angiogenic factors such as vascular endothelial growth factor-A (VEGF-A), VEGF-C, tumor necrosis factor alpha (TNF-a) and anti-angiogenic factors such as soluble VEGF Receptor-1 (VEGF-R1), VEGF-R3, programmed death ligand-1 (PD-L1), pigment epithelium derived factor (PEDF), angiostatin, endostatin, thrombospondin-1 (TSP1) and TSP2 (Ambati et al., 2006; Azar, 2006; Clements and Dana, 2011; Cursiefen et al., 2005; Fibbi et al., 1998; Jin et al., 2011; Ma et al., 2006; Stuart et al., 2003) . In pro-inflammatory conditions, this balance shifts towards pro-angiogenic factors, resulting in the ingrowth of blood and lymph vessels into the cornea followed by edema and loss of visual acuity. Angiogenic inflammation of the cornea is a major cause of corneal blindness in the world (Clements and Dana, 2011; Lee et al., 1998) . Despite recent progress, our understanding of the molecular mechanisms governing corneal angiogenic privilege remains incomplete.
The secreted Ly6/uPAR-related protein-1 (SLURP1) is an 88 amino acids member of the leukocyte antigen-6 (Ly6) family of proteins (Loughner et al., 2016) . SLURP1 is expressed abundantly in the cornea and moderately in oral mucosa, skin and other epithelia, where it is secreted into tear, saliva, sweat, and urine (Adermann et al., 1999; Norman et al., 2004) . It is also expressed in bronchial epithelial cells, a variety of immune cells, primary sensory neurons, and the retina (Fujii et al., 2014; Horiguchi et al., 2009; Mastrangeli et al., 2003; Matsumoto et al., 2012; Moriwaki et al., 2007 Moriwaki et al., , 2009 ).
SLURP1 is a ligand of a7-nAchR and a late marker of epidermal differentiation (Chimienti et al., 2003; Favre et al., 2007; Horiguchi et al., 2009) . Mutations or deletions in SLURP1 cause hyperkeratotic palmoplantar disorder Mal-de-Meleda (Eckl et al., 2003; Fischer et al., 2001; Hu et al., 2003; Ward et al., 2003) . Slurp1-null mice develop severe palmoplantar keratoderma with elevated keratinocyte proliferation, reduced adiposity, protection from obesity on a high-fat diet, and accumulation of lipid droplets in the stratum corneum, reminiscent of Mal-de-Meleda (Adeyo et al., 2014) . Previously, we reported that Slurp1 serves as an immunomodulatory switch that keeps the cornea free of inflammation and is rapidly downregulated in pro-inflammatory conditions allowing helpful inflammation when needed (Swamynathan et al., 2012 (Swamynathan et al., , 2015 Swamynathan and Swamynathan, 2014) . We also demonstrated that SLURP1 modulates corneal homeostasis by serving as a soluble scavenger of urokinase-type plasminogen activator (uPA) (Swamynathan and Swamynathan, 2014) . The immunomodulatory role of SLURP1 and the redundant nature of diverse pathways that govern corneal avascularity raise the possibility that SLURP1 plays a role in maintaining the cornea avascular. Consistent with this possibility, genome-wide comparison of gene expression in sutureand alkali burn-induced murine corneal neovascularization (CNV) identified Slurp1 as one of the highly downregulated genes, strongly implying its involvement in regulation of corneal angiogenic privilege (Jia et al., 2011) . Here, we have examined the role of SLURP1 in regulating angiogenesis by evaluating its effect on human umbilical cord vascular endothelial cell (HUVEC) tube formation in vitro. The results presented here demonstrate that SLURP1 suppresses HUVEC tube formation by blocking nuclear translocation of NFkB, and suggest a potential role for SLURP1 in corneal angiogenic privilege.
Materials and methods

Cells and reagents
Primary HUVEC cells from pooled donors were obtained from Lonza (Portsmouth, NH) and maintained in Endothelial Growth Medium-2 (EGM2). Recombinant human SLURP1 was expressed in E. coli and partially purified on Ni-ion columns. Mock purified protein from an E. coli strain without SLURP1 expression vector served as control protein (CP). TNF-a was purchased from Thermo Scientific (Pittsburgh, PA), Vitronectin from Peprotech (Rocky Hill, NJ), Collagen-1 from BD Biosciences (San Jose, CA), Collagen-IV and Matrigel-GFR from Corning (Corning, NY), and Fibronectin from Sigma-Aldrich (St Louis, MO).
Corneal angiogenesis by alkali burn
Alkali burn-induced CNV, widely used for studying angiogenic inflammation (Jia et al., 2011; Kubota et al., 2011; Parikh et al., 2011; Yoshizuka et al., 1981) , was used to induce corneal angiogenesis in 8-to 10-week old mice of mixed background. Mice were anesthetized by intraperitoneal injection of a mix of ketamine and xylazine. Proparacaine eye drops were used to further anesthetize the corneas. Filter discs soaked in 1.0 M NaOH were placed on central cornea for 20 s, rinsed thoroughly with a gentle stream of 20 ml phosphate buffered saline (PBS) and allowed to recover. Progression of alkali burn-induced angiogenesis was tracked by imaging the corneas on days 0, 2, 7 and 13 post-alkali exposure using a slit-lamp biomicroscope. Corneal expression of Slurp1 at these time points was measured by QPCR, immunoblots and immunofluorescent stain as before (Swamynathan et al., 2015) . Mice used in these experiments were housed in an AAALACapproved animal facility. All procedures were approved by the University of Pittsburgh Institutional Animal Care and Use Committee (IACUC protocol# 15066259) and conformed to the guidelines set by the Association for Research in Vision and Ophthalmology (ARVO).
HUVEC tube formation assay
We used HUVEC tube formation assay, which measures the ability of endothelial cells plated at sub-confluent densities with the appropriate extracellular matrix support, to form capillary-like structures (tubes) to model the reorganization stage of angiogenesis. HUVEC cells were maintained in endodermal growth medium-2 (EGM2). Cells in passages P3 to P6 were pre-treated with TNF-a (10 ng/ml), and SLURP1 (1 mg/ml) or vehicle control for 15 min in endodermal basal medium-2 (EBM2) þ 0.25% Fetal Calf Serum. Pretreated cells were seeded on Matrigel-GFR (Growth Factor reduced) with or without SLURP1. Tubes were allowed to form for 18e24 h at 37 C in a humidified chamber with 5% CO 2 in air. Fluorescent images were captured after staining with Calcein-AM, and analyzed using MetaMorph software (Molecular Devices; Sunnyvale, CA).
HUVEC viability assay
HUVEC cells were plated at a density of 25 Â 10 3 cells per well in a 96-well plate in EGM2. After the cells adhered, TNF-a and SLURP1 was added in EBM2þ0.5% FBS. After 24 h, the number of viable cells was measured by adding Celltiter blue, incubating for 1 h in CO 2 incubator and measuring fluorescence at 590 nm with excitation set at 530 nm.
HUVEC proliferation assay
HUVEC cells were seeded in a 96 well plate at a density of 5 Â 10 3 cells per well in EGM2 and allowed to adhere overnight.
Medium was changed to EBM2 with 0.5% FBS for 6 h and then treated with 10 ng/ml TNF-a and 1 mg/ml SLURP1. The number of cells was measured after 24 h using Celltiter blue as above.
RNA extraction, reverse transcription and QPCR
Relative expression of cytokines was quantified by QPCR 4 h after SLURP1 or control protein pretreated HUVEC cells were exposed to 10 ng/ml TNF-a. Total RNA was isolated using EZ-10 spin column total RNA mini-prep kit from Bio Basic Inc. (Amherst, NY), 300 ng of which was used for cDNA synthesis with Mouse Moloney Leukemia Virus reverse transcriptase (Promega, Madison, WI). SYBR Green gene expression assays were performed in triplicate in ABI StepOne Plus thermocycler with validated primers from realtimeprimers.com (Elkins Park, PA) using 18S rRNA, RPL13A or Actin-B as endogenous control. QPCR results were analyzed using StepOne software (Applied Biosystems). Results shown are the average of three independent experiments.
Adhesion assay
HUVEC cells maintained overnight in EBM2þ0.5% serum were dissociated using accutase, pre-incubated with control protein or SLURP1 for 30 min followed by incubation with or without TNF-a for 30 min. Treated HUVEC cells seeded in a 96-well plate coated with Collagen-1 (5 mg/cm 2 ), Collagen-IV (2), Fibronectin (2 mg/cm 2 ),
2 ), were allowed to adhere for 30 min in humidified CO 2 incubator. Adherent HUVEC cells were stained by crystal violet and relative adherence measured by solubilizing crystal violet in 20% acetic acid and measuring absorbance at 590 nm using Biotek Synergy-II plate reader (Biotek Instruments, Winooski, VT).
Gap filling assays
A gap was introduced in confluent HUVEC cells with a 200 ml tip.
The cells were then washed with PBS and incubated in EBM2þ0.5%
FBS with 1 mg/ml control protein or SLURP1 in the presence or absence of 10 ng/ml TNF-a. Four distinct areas of the gaps were photographed immediately after gap generation (0 h) and 18 h later, using a Nikon TS100 inverted microscope with a 2X objective and a Spot RT camera (Diagnostics Instruments; Sterling Heights, MI) and quantified by MetaMorph. The images were taken at the same spot at 0 and 18 h after wounding using reference markings just outside of the imaged area.
Immunoblots
Mice were euthanized by CO 2 asphyxiation followed by cervical dislocation at indicated time points after alkali-burn, and corneal lysate was prepared by homogenizing dissected corneas in RIPA buffer (10 mM Tris-Cl (pH 8.0), 1 mM EDTA, 1% Triton X-100, 0.1% Sodium deoxycholate, 0.1% SDS, 140 mM NaCl and 1 mM PMSF). Equal amount of protein quantified by bicinchoninic acid (BCA) (Pierce, Rockford, IL) method was separated on NuPage 4e12% acrylamide gradient gels using MES SDS running buffer (Invitrogen, Carlsbad, CA), transferred to polyvinylidene difluoride (PVDF) membranes and probed with 1:200 dilution of rabbit anti-mouse Slurp1 antibody (a kind gift from Dr. Misawa, Keio University, Tokyo, Japan) Swamynathan et al., 2012) . IRDye-800 goat anti-rabbit secondary antibody was used to detect primary antibody-bound protein bands using Odyssey scanning system from LI-COR (Lincoln, NE). The membrane was re-probed with goat anti-actin antibody (Santa Cruz Biotechnology, Santa Cruz, CA. catalog # sc 1616, Lot #D0609) and IRDye-680 donkey anti-goat antibody to ensure equal loading.
For NFkB nuclear translocation studies, HUVEC cells were grown overnight in EBM2þ0.5% FBS and pre-treated with control protein or SLURP1 for 30 min and then exposed to TNF-a (10 ng/ml) for 10, 20 or 30 min. Nuclear protein was extracted using nuclear extraction buffer (20 mM HEPES, 500 mM NaCl, 0.2 mM EDTA, 0.5 mMDTT, 1.5 mM MgCl2, 1 mM PMSF) and quantified by BCA method. Equal quantities of nuclear protein were electrophoresed and transferred to PVDF membranes as above, and probed with 1:1000 dilution of mouse anti-NFkB antibody (Cell Signaling Technology, Danvers MA. Catalog # 6956, Lot # 6). IRDye goat antimouse secondary antibody was used to detect primary antibodybound protein bands as above. Membranes were stripped of the antibody with 1x stripping buffer (NewBlot IR Stripping buffer, LI-COR part # 929-40028) for 15 min at room temperature on a rocker, washed 3 times with PBS (5 min each) and re-probed with anti-TATA binding protein antibody (Cell Signaling Technology, Catalog # 44069; Lot # 1) to ensure equal loading of nuclear extract.
Immunofluorescent stain
HUVEC cells grown on vitronectin-coated glass cover slips in EBM2þ0.5% FBS were pre-treated with control protein or SLURP1 for 30 min and exposed to TNF-a (10 ng/ml) for additional 10, 20 or 30 min, fixed in buffered 3% paraformaldehyde for 20 min, washed thrice for 5 min each with PBS, permeabilized with 0.1% triton in PBS, washed thrice with PBS for 5 min each, blocked with 10% goat serum in PBS for 1 h at room temperature in a humidified chamber, washed twice with PBS for 5 min each, incubated with a 1:500 dilution of the mouse anti-NFkB primary antibody overnight in a humidified chamber at 4 C, washed thrice with PBS for 5 min each, incubated with secondary antibody (Alexafluor 488-coupled goat anti-mouse IgG from Molecular Probes, Carlsbad, CA) at a 1:300 dilution for 1 h at room temperature, washed thrice with PBS containing 0.1% Tween-20 (PBST) for 5 min each, counter-stained with 4 0 ,6-diamidino-2-phenylindole (DAPI), and coverslipped using Aqua-Poly/Mount (Polysciences, Warrington, PA). After drying overnight, the coverslips were sealed with clear nail polish and the images collected using Olympus IX81 confocal microscope.
Results
Slurp1 is downregulated during alkali burn-induced corneal neovascularization
We utilized alkali burn-a well-established model of corneal angiogenesis (Jia et al., 2011; Kubota et al., 2011; Yoshizuka et al., 1981; Zhang et al., 2006) -to determine how Slurp1 expression changes during angiogenic inflammation. CNV was evident by 7 days post-alkali burn and was retained at 13 days post-alkali burn (Fig. 1A) . QPCR revealed and immunoblots confirmed that Slurp1 expression was significantly downregulated at 2, 7 and 13 days post-alkali burn, compared with that in the naïve contralateral eyes ( Fig. 1B and C) . Consistent with these results, immunofluorescent stain revealed abundant expression of Slurp1 in the contralateral corneal epithelium, but not the alkali-burned corneas (Fig. 1D) . Alkali-burned corneal stroma was edematous and contained on average, 23,950, 18,153 and 23,605 cells per mm 2 of stroma at days 2, 7 and 13 respectively, compared with 2,885, 2894 and 4030 per mm 2 stroma in control corneas, indicating significant immune infiltrate in alkali-burned corneas (n ¼ 4; p ¼ 0.014, 0.0001, and 0.0037, respectively). Together, these results reveal that Slurp1 is significantly downregulated during alkali-burn induced CNV, indicating a potential role for Slurp1 in regulating corneal angiogenic inflammation.
SLURP1 suppresses HUVEC tube formation
Next, we employed in vitro HUVEC tube formation assays to directly determine the effect of SLURP1 on angiogenesis. Control protein-treated HUVEC cells formed tubes in the absence of any additional stimulation when plated in EBM2þ0.25% FBS in matrigel-GFR ( Fig. 2A) . Addition of recombinant SLURP1 partially suppressed HUVEC tube formation (Fig. 2B) . Addition of TNF-a further stimulated HUVEC tube formation, which was efficiently inhibited by SLURP1 (Fig. 2C and D) . Morphometric measurements from six independent replicates revealed that the inclusion of TNFa increased the mean HUVEC tube length, tube area and number of branch points (Fig. 2EeG) . Addition of SLURP1 partially suppressed the HUVEC tube length, tube area, and the number of branch points. The extent of this suppression was more, and statistically significant when SLURP1 was added to the TNF-a-stimulated HUVEC cells (Fig. 2EeG) . The viability and proliferation of HUVEC cells were not significantly affected by SLURP1 (Fig. 3A and B) , suggesting that SLURP1-mediated suppression of HUVEC tube formation is not an indirect outcome of their decreased viability and/or proliferation. Taken together, these results suggest that SLURP1 suppresses TNFa-stimulated HUVEC tube formation without altering their viability or proliferation.
SLURP1 suppresses the TNF-a-induced expression of IL-8 and TNF-a in HUVEC
To determine if cytokine expression is affected following alkali burn in the cornea, we examined the relative levels of cytokine transcripts in 2-and 7-day-post-alkali-burned mouse corneas. We Fig. 1 . Effect of alkali-burn on Slurp1expression in mouse corneas. (A) Bright field images of naïve and alkali-burned eyes at post-burn days 0, 2, 7 and 13 showing their external appearance. Note that CNV is apparent by post-burn day 7, and persists at day 13. (B) Slurp1 transcript levels in corneas from alkali-burned eyes (BE) relative to that in corneas from naïve contralateral eyes (CE) on post-burn days 2, 7 and 13, quantified by QPCR using pyruvate carboxylase (PCX) as endogenous control and plotted on log scale. (C) Slurp1 protein on post-burn days 2, 7 and 13, detected by immunoblots with anti-Slurp1 antibody (white arrow). The blot was re-probed with anti-actin antibody for loading control (black arrow). Slurp1:Actin signal intensity ratios determined by densitometry are shown on the right side, reflecting relative amounts of Slurp1 protein in alkali-burned corneas. (D) Slurp1 protein in mouse corneas on post-burn days 2, 7 and 13, detected by immunofluorescent stain with anti-Slurp1 antibody (red). Nuclei were counterstained blue by DAPI. Images procured from sections incubated with no primary antibody controls are shown (Di and Dv). Note that corneal epithelial expression of Slurp1 is abundant in the control (Dii-Div; arrows) and sharply decreased in alkali-burned (Dvi-Dviii; arrowheads) corneas. BE, Alkali-burned eye; CE, Contralateral eye. Scale bar, 20 mm. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) observed elevated expression of transcripts encoding proinflammatory cytokines Ifna, Ifnb, Cxcl1, Cxcr2 and Tnfa in mouse corneas at days 2 and 7 post-alkali-burn (Fig. 4A) , consistent with the previous studies that reported similar upregulation (Saika et al., 2005; Sotozono et al., 1997) . Considering that TNF-a is a potent cytokine that exerts its effects by stimulating the expression of a host of other cytokines, we measured the effect of SLURP1 on expression of different cytokines in HUVEC pre-treated with control protein or SLURP1, followed by TNF-a for 4 h. QPCR revealed that the expression of IL-8 was highly stimulated by TNFa, and that this stimulation was subdued in the presence of SLURP1 in HUVEC (Fig. 4B) . Similarly, auto-stimulation of TNF-a expression in TNF-a-treated HUVEC cells was subdued by SLURP1 treatment (Fig. 4B) . The expression of other cytokines tested was not affected by TNF-a and SLURP1. Thus, SLURP1-mediated suppression of HUVEC tube formation is associated with decreased expression of IL-8 and TNF-a.
SLURP1 modulates HUVEC interaction with the extracellular matrix, and migration
As angiogenic potential of the endothelial cells depends on both their interaction with the extracellular matrix (ECM) and their ability to migrate through the ECM, we evaluated the effect of SLURP1 on interaction of HUVEC cells with ECM components. Relative to control protein, treatment with either SLURP1 or TNF-a alone suppressed the adhesion of HUVEC cells to collagen-1-, collagen-4-vitronectin-, or fibronectin-coated plates. Treatment with both SLURP1 and TNF-a further decreased the affinity of this interaction with collagen-4, vitronectin and fibronectin (Fig. 5) . Next, we determined the effect of SLURP1 on HUVEC cell migration in gap filling assays. TNF-a stimulated HUVEC cell migration, while addition of SLURP1 suppressed it (Fig. 6) . Together, these results suggest that SLURP1 modulates HUVEC cell interaction with the ECM, and their migration.
SLURP1 suppresses TNF-a-stimulated nuclear translocation of NFkB
Considering that the stress-activated transcription factor NFkB is a major participant in TNF-a-stimulated angiogenic inflammation (Reynolds et al., 2014) , we examined if TNF-a-triggered nuclear localization of NFkB is affected in HUVEC cells. Immunoblots revealed efficient nuclear translocation of NFkB upon TNF-a treatment, which was suppressed in HUVEC cells exposed to SLURP1 (Fig. 7A and B) . Uniformity in nuclear extract preparation and loading was ensured by re-probing with anti-TBP antibody as control ( Fig. 7A and B) . Next, we pre-treated the HUVEC cells with control protein or SLURP1 for 30 min, exposed to TNF-a, and fixed at 0, 10, and 30 min after TNF-a treatment, and the sub-cellular localization of NFkB was evaluated by immunofluorescent staining. Treatment with TNF-a induced nuclear localization of NFkB in control protein treated HUVEC cells within 10 min but not in SLURP1-treated cells, where it remained largely within the cytoplasm even after 30 min of treatment (Fig. 7C) . Together, these results suggest that SLURP1 suppresses TNF-a-stimulated nuclear translocation of NFkB in HUVECs.
Discussion
Corneal angiogenic privilege depends on the balance between proangiogenic and antiangiogenic factors (Azar, 2006; Clements and Dana, 2011) . The normally avascular cornea may vascularize when the equilibrium between pro-and anti-angiogenic factors is tilted towards pro-angiogenic factors resulting in the growth of new blood vessels from pre-existing vasculature at the pericorneal plexus. In view of the critical role of the cornea in ensuring proper vision, it is important to identify the different molecular mechanisms that regulate corneal angiogenic privilege. In this report, we have presented evidence that Slurp1, one of the most abundantly expressed proteins in the cornea, is sharply downregulated in the alkali burn model of mouse CNV, and that in HUVEC cells cultured in vitro, SLURP1 suppresses TNF-a-stimulated (i) tube formation (tube length, area and number of branch points) without affecting their survival and/or proliferation, (ii) IL-8, and TNF-a production, (iii) rate of cell migration, (iv) adhesion to different ECM components, and (v) nuclear localization of NFkB. Consistent with our observations, comparison of genome-wide gene expression in both suture-and alkali burn-induced CNV detected Slurp1 mRNA as one Fig. 4 . Relative cytokine levels in alkali burned corneas and the effect of SLURP1 on TNF-a-induced cytokine expression in HUVEC. A. Relative levels of transcripts encoding Ifna, Ifnb, Tnfa, Cxcl1 and Cxcr2 in alkali-burned mouse corneas on post-burn days-2 and -7. RNA was extracted from control contralateral and alkali-burned mouse corneas on post-burn days-2 and -7, and the transcript levels tested by QPCR. B. Compound panel chart showing the effect of SLURP1 on expression of different cytokine transcripts in HUVEC cells. RNA was extracted from HUVEC cells pretreated with SLURP1 or control protein and exposed to TNF-a for 4 h and transcript levels measured by QPCR. Y-axis is presented as a compound panel, with the scale shifting to multiples of 10 after 5, to accommodate the large increase in IL-8 expression in HUVEC cells following TNF-a treatment. Results shown are the average of three independent experiments. of the highly downregulated genes (Jia et al., 2011) . Together, these results indicate a potential role for SLURP1 in corneal angiogenic privilege by blocking nuclear translocation of NFkB, a key transcription factor that regulates cellular responses to proinflammatory stimuli (Fig. 8) .
Fitting with the essential nature of corneal transparence for vision, pro-and anti-angiogenic factors have been studied intensively, revealing the important role of innate immune cells in CNV. For instance, CD11bþmacrophages are required for corneal lymphangiogenesis under pathological conditions (Maruyama et al., 2005 (Maruyama et al., , 2012 . Similarly, Th17 cells promote angiogenesis in autoimmune diseases and malignancies through IL-17 . In contrast, cell surface molecules FAS-L, VEGF-R3 and PD-L1, as well as secreted molecules TGFb and soluble VEGF-R1 promote corneal avascularity by inhibiting infiltration and angiogenic activity of leukocytes (Ambati et al., 2006; Azar, 2006; Cursiefen et al., 2006; El Annan et al., 2010; Jin et al., 2011; Keir et al., 2008; Morris et al., 2012; Stuart et al., 2003; Tandon et al., 2010) . Though the present data coupled with our previous reports (Swamynathan et al., 2012 (Swamynathan et al., , 2015 Swamynathan and Swamynathan, 2014) suggest that SLURP1 is an important secreted component of the corneal innate immune response, in vivo experiments with Slurp1-knockout mouse corneas would be necessary to provide definitive evidence in favor of the role of Slurp1 as an antiangiogenic molecule. HUVEC-derived data presented here only provide proof of concept that SLURP1 is a potentially valuable target for managing diseases involving corneal neovascularization. The in vivo relevance and applicability of these findings remain to be established.
Inflammation is the common denominator in CNV induced by microbial infection, chemical injury, autoimmune disorders, contact lens induced irritation, and post-corneal transplant complications (Clements and Dana, 2011; Lee et al., 1998) . Previously, we suggested an immunomodulatory role for Slurp1 in the mouse cornea based on our findings that (i) corneal expression of Slurp1 is abrogated upon Herpes Simplex Virus type-1 (HSV-1) infection, corneal exposure to bacterial lipopolysaccharide (LPS) or fungal cell wall zymosan-A, concurrent with neutrophil infiltration, and (ii) SLURP1 is downregulated in human corneal limbal epithelial cells exposed to pro-inflammatory interleukins IL-4 and IL-13 (Swamynathan et al., 2012 (Swamynathan et al., , 2015 . In adenoviral keratitis model of mouse corneal inflammation, over-expression of Slurp1 hindered neutrophil influx into corneas, providing further support for the immunomodulatory function of Slurp1 (Swamynathan et al., 2012) . We also demonstrated that Slurp1 serves as a soluble scavenger of urokinase, the ligand for urokinase-type plasminogen activator receptor (uPAR) that plays a critical role in angiogenic inflammation (Blasi and Carmeliet, 2002; Montuori and Ragno, 2014; Smith and Marshall, 2010; Swamynathan and Swamynathan, 2014) . The present data, that SLURP1 suppresses HUVEC tube formation by blocking NFkB activity, further bolsters the role of SLURP1 as an immunomodulatory molecule.
Aberrant cell proliferation, migration, and interaction with ECM are key features of angiogenic inflammation associated with corneal pathologies (Azar, 2006; Clements and Dana, 2011; Lim et al., 2009) . Treatment of HUVEC cells with either SLURP1 or TNF-a suppressed their adhesion to collagen-1-, collagen-4-, vitronectin-, or fibronectin-coated plates (Fig. 5 ). This inhibitory effect was enhanced when they both were treated together. These results are consistent with the previous reports that TNF-a inhibits human endothelial cell adhesion to vitronectin, laminin, and fibronectin by suppressing the expression of a v b 3 integrin (Defilippi et al., 1991) , a 6 b 1 integrin (Defilippi et al., 1992) , and a 5 b 1 integrin (Rotundo et al., 2002) . Whether SLURP1 has a similar inhibitory effect on expression of these or other integrins remains to be determined.
An important observation in this study is that SLURP1 blocks HUVEC tube formation by suppressing nuclear localization of NFkB (Fig. 7) . Several studies in the past have addressed the changes in cytokine expression and nuclear translocation of NFkB following alkali burn in the mouse corneas. Cytokines IL-1a, IL-1b, IL-6, IL-10 and TNF-a are overexpressed in alkali-burned corneas (Sotozono et al., 1997) . Consistent with the involvement of NFkB in generation of alkali burn-induced inflammatory environment, macrophage invasion, and expression of cytokines are increased in alkali burned corneas, and are decreased upon inhibition of NFkB (Saika et al., 2005) . Elevated expression of pro-inflammatory cytokines in TNF-a-activated HUVEC cells and alkali burned corneas, and their decreased production in the presence of SLURP1 (Fig. 4) is consistent with cytoplasmic retention of NFkB by SLURP1 (Fig. 7) . Previously, we have reported that Slurp1 modulates corneal homeostasis by serving as a soluble scavenger of uPA (Swamynathan and Swamynathan, 2014) . Understanding the effect of SLURP1 on (i) the stability of IkB which binds NF-kB and inhibits its nuclear localization, (ii) upstream signaling pathways that feed into NFkB, (iii) the expression of other pro-angiogenic cytokines, and (iv) additional factors that interact with SLURP1 will be essential to completely understand the molecular mechanism underlying antiangiogenic function of SLURP1.
Although CNV occurs in the corneal stroma, many corneal epithelium-expressed factors play important roles in regulating it (Bock et al., 2013; Kinoshita et al., 2001) . High level of expression of VEGF-R3 in the corneal epithelium suppresses inflammatory corneal angiogenesis by serving as a sink for VEGF which would Fig. 6 . Effect of SLURP1 on HUVEC cell migration. Gaps were generated in confluent HUVEC cells treated with control protein or SLURP1 and stimulated with TNF-a. Images captured from the same spots (detected using reference markings just outside of the imaged areas; also discerned using background marks indicated by arrowheads) at 0 h and after 18 h of gap-filling were used to quantify the relative area filled in. Representative images are shown on the top (A), and the mean results from four replicates are shown at the bottom (B). Immunoblots with HUVEC nuclear extracts (blots probed with anti-NFkB and anti-TBP antibody). HUVEC cells were pre-treated with control protein or SLURP1 for 30 min, exposed to TNF-a, nuclear extract prepared at 0, 10, 20 and 30 min after TNF-a treatment, separated by SDS-PAGE, and NFkB and TBP detected by immunoblots as indicated. (B) Relative quantities of nuclear NFkB estimated by densitometric scans. NFkB and TBP band intensities were quantified by densitometric scans and NFkB:TBP ratios plotted. (C) Immunofluorescent Staining for NFkB. HUVEC cells were pre-treated with control protein (aei) or SLURP1 (jer) for 30 min, exposed to TNF-a, fixed at 0, 10, and 30 min after TNF-a treatment, and the sub-cellular localization of NFkB detected by immunofluorescent staining (green). Nuclei are stained blue with DAPI (blue). TNF-a induced nuclear localization of NFkB in control protein treated HUVEC cells within 10 min (f and i; arrows) but not in SLURP1-treated cells, where it remained within the cytoplasm even after 30 min of treatment (o and r; arrowheads). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) otherwise stimulate inflammatory CNV via macrophage recruitment (Cursiefen et al., 2004b Jin et al., 2011) . Similarly, corneal epithelial expression of PD-L1 helps block angiogenesis . Our results add SLURP1 to the list of anti-angiogenic factors in the corneal epithelium, and suggest that SLURP1-based therapy may prove useful in controlling inflammatory CNV. In view of their redundant nature, it will be beneficial to evaluate combinatorial therapy targeting multiple pro-and anti-angiogenic factors such as PD-L1, thrombospondin-1, a5-integrin, and VEGF-A, to manage pathological CNV Cursiefen et al., 2011; . As the corneal transplants onto vascularized graft beds are rejected at a high frequency (Bachmann et al., 2010) , identification of SLURP1 as an anti-angiogenic factor provides a new potential target for decreasing graft rejection. Considering that anti-VEGF therapy increases the corneal graft survival rate (Cursiefen et al., 2004a; Yatoh et al., 1998) , and that SLURP1 has potent anti-angiogenic properties, we anticipate that maintaining optimal levels of SLURP1 (either by topical applications or through stimulating endogenous expression) in the host and the graft corneas is likely to improve graft survival.
Conclusions
The results presented in this report (i) demonstrate that SLURP1 suppresses HUVEC tube formation by blocking the nuclear translocation of NFkB, (ii) suggest a potential role for SLURP1 in promoting corneal angiogenic privilege, and (iii) highlight yet another means by which the corneal epithelium contributes to the overall health of the cornea. 
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